by EpicentRx | Oct 17, 2024 | Blog
We often write figuratively about climate change since lead EpicentRx therapies, RRx-001 (nibrozetone) and AdAPT-001, “heat up” “cold”, non-immunogenic tumors, that is, they make them more immunogenic and treatment sensitive. However, methane (CH4), a contributor to...
by EpicentRx | Oct 16, 2024 | Blog
Ozempic butt. Ozempic tongue. Ozempic fingers. Ozempic burps. Ozempic dreams. Ozempic diarrhea. Ozempic hair. The list of side effects from glucagon-like peptide-1 (GLP-1) agonists Ozempic/Wegovy, and Mounjaro/Zepbound seems to expand over time in inverse proportion...
by EpicentRx | Oct 14, 2024 | Blog
“Your introduction to transduction below” Transduce Definition (verb): 1) To transfer genetic material, to cause to undergo transduction “AdAPT-001 transduces cancer cells with its TGFβ trap” 2) To convert from one form to another...
by EpicentRx | Oct 11, 2024 | Blog
“Earoma” When you smell something while driving and feel the need to turn down the radio to smell it better.
by EpicentRx | Oct 10, 2024 | Blog
As we wrote in a previous (and longer) post about RRx-001 (nibrozetone), we idly wondered, after having binge watched the trippy Apple TV sci-fi-thriller, Dark Matter, about the multiverse and the “what-ifs” in life, where our lead therapy, AdAPT-001, would have ended...
